Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$20,554,458
+$11,237,187 QoQ
Shares Held
81,682
+90.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
#598
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simplicity Wealth,LLC holds $64,075,335 across 13 Drug Manufacturers - General names. ABBV ranks #1 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
81,682 | $20,554,458 | |
| 2 | JNJ |
Johnson & Johnson
|
53,196 | $13,510,188 | |
| 3 | LLY |
ELI LILLY & Co
|
9,693 | $11,626,075 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,267 | $6,844,809 | |
| 5 | AMGN |
Amgen Inc
|
10,539 | $3,816,382 | |
| 6 | PFE |
Pfizer Inc
|
109,120 | $2,627,609 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,730 | $1,355,628 | |
| 8 | NVS |
Novartis AG
|
5,984 | $937,812 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,554,458 | 81,682 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $9,317,271 | 42,840 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,200,176 | 31,512 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $6,995,286 | 30,212 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $10,255,690 | 55,251 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,199,409 | 20,043 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $971,485 | 5,467 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,851,413 | 14,439 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $23,075,443 | 134,535 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $22,020,806 | 120,927 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $213,393 | 1,377 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||